Status:
TERMINATED
Initiative to Minimize Disparities in Postoperative Prostate Cancer Care
Lead Sponsor:
Albert Einstein Healthcare Network
Conditions:
Post Prostatectomy
Eligibility:
MALE
Brief Summary
Einstein Healthcare Network in North Philadelphia serves a predominantly underserved medical community. The investigators routinely see patients who cannot afford absorbent pads after prostate surgery...
Detailed Description
When detected early and managed with appropriate surgical treatment, such as radical prostatectomy, Prostate cancer prognosis is excellent, but recovery may be associated with significant transient im...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- History of prostate cancer
- Scheduled for radical prostatectomy during a designated academic year
- Reside within Health Enterprise Zone (HEZ) of North Broad Street
- Median annual household income \< $50,000
- Patient feels that they would struggle to afford absorbent pads and Tadalafil based on their annual income
- Patient must have no history of stress urinary incontinence prior to surgery
- Exclusion Criteria
- Patient's who do not meet the inclusion criteria above
- Patients who meet all inclusion criteria above, but do not want to use absorbent pads secondary to history of hypersensitivity/allergy to absorbent pads
- Patients with cognitive impairment will be excluded from the study
Exclusion
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03755492
Start Date
April 1 2019
End Date
July 20 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert Einstein Healthcare Network
Philadelphia, Pennsylvania, United States, 19141